Responsiveness of Intrinsic Subtypes to Adjuvant Anthracycline Substitution in the NCIC.CTG MA.5 Randomized Trial

PURPOSE: Recent studies suggest that intrinsic breast cancer subtypes may differ in their responsiveness to specific chemotherapy regimens. We examined this hypothesis on NCIC.CTG MA.5, a clinical trial randomizing premenopausal women with node-positive breast cancer to adjuvant CMF (cyclophosphamid...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Cheang, Maggie C.U., Voduc, K. David, Tu, Dongsheng, Jiang, Shan, Leung, Samuel, K. Chia, Stephen, Shepherd, Lois E., Levine, Mark N., Pritchard, Kathleen I., Davies, Sherri, Stijleman, Inge J., Davis, Carole, Ebbert, Mark T. W., Parker, Joel S., Ellis, Matthew J., Bernard, Philip S., Perou, Charles M., Nielsen, Torsten O.
Formato: Artigo
Idioma:Inglês
Publicado em: 2012
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3743660/
https://ncbi.nlm.nih.gov/pubmed/22351696
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-11-2956
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados